SCHEMBL784033

SCHEMBL784033

CC(C)OP(=O)(O)S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6681748 0.75 CTSA (0.50)
SCHEMBL268599 0.75 CTSA (0.50)
SCHEMBL11658682 0.75
SCHEMBL3061757 0.75 CTSA (0.50)
Phosphorylisopropane SCHEMBL82996 0.75
SCHEMBL12240712 0.74
SCHEMBL3822462 0.74
SCHEMBL13020373 0.73
SCHEMBL10579482 0.73
Phosphorylisopropane SCHEMBL17670024 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3102215-A2 4'-DIFLUOROMETHYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF INFLUENZA RNA REPLICATION Riboscience LLC (US) 2016-12-14 EP claimed
WO-2015120237-A2 4'-DIFLUOROMETHYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF INFLUENZA RNA REPLICATION RIBOSCIENCE LLC (US) 2015-08-13 WO claimed
US-11773126-B2 Substituted nucleosides, nucleotides and analogs thereof Janssen Pharmaceuticals, Inc. (US) 2023-10-03 US disclosed
US-20230201236-A1 SPIROCYCLIC NUCLEOSIDE ANALOGUES FOR THE TREATMENT OF HEPATITIS E Janssen Pharmaceuticals, Inc. 2023-06-29 US disclosed
US-20230201239-A1 ALKYNYL NUCLEOSIDE ANALOGS FOR TREATMENT OF HEPATITIS E Janssen Pharmaceuticals, Inc. 2023-06-29 US disclosed
US-20230167151-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF JANSSEN PHARMACEUTICA NV (BE) 2023-06-01 US disclosed
US-20230159449-A1 LIPID FORMULATIONS CONTAINING NUCLEIC ACIDS AND METHODS OF TREATMENT FOR CYSTIC FIBROSIS ARCTURUS THERAPEUTICS, INC. 2023-05-25 US disclosed
CN-105979951-B 4' -difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication 里博科学有限责任公司 2020-12-25 CN disclosed
CN-111194217-A 4 '-fluoro-2' -methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication 里伯赛恩斯有限责任公司 2020-05-22 CN disclosed
WO-2019032607-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2019-02-14 WO disclosed
US-20180194793-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF Janssen Biopharma, Inc. 2018-07-12 US disclosed
US-20130253181-A1 METHODS OF PREPARING SUBSTITUTED NUCLEOTIDE ANALOGS VERTEX PHARMACEUTICALS INC. (US) 2013-09-26 US disclosed
US-20130165400-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF ALIOS BIOPHARMA, INC. (US) 2013-06-27 US disclosed
US-20130164261-A1 SUBSTITUTED NUCLEOTIDE ANALOGS ALIOS BIOPHARMA, INC. (US) 2013-06-27 US disclosed
US-20120070415-A1 AZIDO NUCLEOSIDES AND NUCLEOTIDE ANALOGS ALIOS BIOPHARMA, INC. (US) 2012-03-22 US disclosed
US-20120071434-A1 SUBSTITUTED NUCLEOTIDE ANALOGS ALIOS BIOPHARMA, INC. (US) 2012-03-22 US disclosed
US-20100331397-A1 2-5A ANALOGS AND THEIR METHODS OF USE ALIOS BIOPHARMA, INC. (US) 2010-12-30 US disclosed
EP-1139738-A1 INSECTICIDAL SEED COATING Syngenta Participations AG (CH) 2001-10-10 EP disclosed
WO-2000035277-A1 INSECTICIDAL SEED COATING SYNGENTA PARTICIPATIONS AG (CH) 2000-06-22 WO disclosed
US-4024049-A Mono and di organophosphite esters as crude oil antifoulants NALCO CHEMICAL COMPANY (US) 1977-05-17 US disclosed